Menu

Arch Therapeutics, Inc. ARTH

Full chart Compare
Set alert

Price alert · ARTH

All alert types
0.00 0.00 (+0.00%)

At closeMay 2, 2025, 4:00 PM EDT

0.0001 Day range 0.2014

52-week range unavailable

Revenue & Expenses

Net Loss → Expenses: $6.98MExpenses → Gross Loss: $2.44KExpenses → Selling, General & Admin: $4.37MExpenses → Research & Development: $670.88KExpenses → Other Expenses: $1.94MRevenue → Cost of Revenue: $75.72KNet Loss$6.98MCost of Revenue$78.16KExpenses$6.98MGross Loss$2.44KSelling, General & Admin$4.37MResearch & Development$670.88KOther Expenses$1.94MRevenue$75.72K

No annual statement lines

ARTH has no annual lines for this statement.